Cellular interactions and bone healing responses to a novel porous tricalcium phosphate bone graft material

Orthopedics

Volumn 27, Issue 1 SUPPL., 2004, Pages

  Fredericks, Douglas C ^a   Bobst, John A ^a   Petersen, Emily B ^a   Nepola, James V ^a   Dennis, James E ^b   Caplan, Arnold I ^b   Burgess, Ann V ^c   Overby, Robyn J ^c   Schulz, Olaf H ^c  

^a UNIVERSITY OF IOWA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c WRIGHT MEDICAL TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE;

ARTICLE; AUTOGRAFT; BONE DEFECT; BONE GRAFT; BONE STRENGTH; BONE TRANSPLANTATION; CELL CULTURE; CELL INTERACTION; CONTROLLED STUDY; DIAPHYSIS; EXTERNAL FIXATOR; FRACTURE HEALING; HISTOPATHOLOGY; HOST CELL; HUMAN; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MESENCHYME CELL; POROSITY; STEM CELL; TIBIA;

BONE AND BONES; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CELL COMMUNICATION; HUMANS; MATERIALS TESTING; WOUND HEALING;

EID: 0742324094     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fernyhough JC, Schimandle JJ, Weigel MC, Edwards CC, Levine AM. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine. 1992; 17:1474-1480.
2. Fowler BL, Dall BE, Rowe DE. Complications associated with harvesting autogenous iliac bone graft. Am J Orthop. 1995; 24:895-903.
3. Laurie SW, Kaban LB, Mulliken JB, Murray JE. Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg. 1984; 73:933-938.
4. Scranton PE Jr. Use of bone graft substitutes in lower extremity reconstructive surgery. Foot Ankle Int. 2002; 23:689-692.
5. Shors EC. Coralline bone graft substitutes. Orthop Clin North Am. 1999; 30:599-613.
6. Chapman MW, Bucholz R, Cornell C. Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg Am. 1997; 79:495-502.
7. Wientroub S, Goodwin D, Khermosh O, Salama R. The clinical use of autologous marrow to improve osteogenic potential of bone grafts in pediatric orthopedics. J Pediatr Orthop. 1989; 9:186-190.
8. LeGeros RZ, Parsons JR, Daculsi G, et al. Significance of the porosity and physical chemistry of calcium phosphate ceramics: bio-degradation-bioresorption. In: Ducheyne P, Lemons JE, eds. Bioceramics: Material Characteristics Versus in vivo Behavior. New York, NY: New York Academy of Sciences; 1988:298.
9. LeGeros RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop. 2002; 395:81-98.
10. Lennon D, Haynesworth S, Bruder S, Jaiswall N, Caplan A. Human and animal mesenchymal projenitor cells from bone marrow: identification of serum for optimal selection and proliferation. In Vitro Cell Develpo Bio. 1996; 32:602-611.
11. Dennis JE, Haynesworth SE, Young RG, Caplan AI. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant. 1992; 1:23-32.
12. Fredericks DC. In vivo evaluation of sintered porous ceramic material for intertransverse process fusion in the sheep model. Eurospine. Nantes, France. 2002.
13. Den Boer FC, Wippermann BW, Blokhuis TJ, Patka P, Bakker FC, Haarman HJ. Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow. J Orthop Res. 2003; 21:521-528.
14. Klein C, de Groot K, Chen W, Li Y, Zhang X. Osseous substance formation induced in porous calcium phosphate ceramics in soft tissues. Biomaterials. 1994; 15:31-34.
15. Wang J, Chen W, Li Y, Fan S, Weng J, Zhang X. Biological evaluation of biphasic calcium phosphate ceramic vertebral laminae. Biomaterials. 1998; 19:1387-1392.
16. Li Y, Zhang X, de Groot K. Hydrolysis and phase transition of alpha-tricalcium phosphate. Biomaterials. 1997; 18:737-741.
17. Radin S, Ducheyne P. Changes in characteristics arising from processing and the effects on invitro-stability of calcium phosphate ceramics. In: Horowitz E, Parr JE, ASTM Committee F-4 on Medical and Surgical Materials and Devices, eds. Characterization and Performance of Calcium Phosphate Coatings for Implants, STP 1196. Philadelphia, Pa: ASTM; 1994.
18. Bobyn JD, Pilliar RM, Cameron HU, Weatherly GC. The optimum pore size for the fixation of porous-surfaced metal implants by the ingrowth of bone. Clin Orthop. 1980; 150:263-270.
19. Chang BS, Lee CK, Hong KS, et al. Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials. 2000; 21:1291-1298.
20. Daculsi G, Passuti N. Effect of the macroporosity for osseous substitution of calcium phosphate ceramics. Biomaterials. 1990; 11:86-87.
21. Gauthier O, Bouler JM, Aguado E, Pilet P, Daculsi G. Macroporous biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone ingrowth. Biomaterials. 1998; 19:133-139.
22. Holmes RE, Bucholz RW, Mooney V. Porous hydroxyapatite as a bone graft substitute in diaphyseal defects: a histometric study. J Orthop Res. 1987; 5:114-121.
23. Nade S, Armstrong L, McCartney E, Baggaley B. Osteogenesis after bone and bone marrow transplantation. The ability of ceramic materials to sustain osteogenesis from transplanted bone marrow cells: preliminary studies. Clin Orthop. 1983; 181:255-263.
24. Grundel RE, Chapman MW, Yee T, Moore DC. Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop. 1991; 266:244-258.